NovaGo Therapeutics

Switzerland
Schlieren, Zurich, Switzerland

Company profile

NovaGo Therapeutics company profile

NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics targeting cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. A strategic partnership with Neurimmune provides access to a unique class of human-derived antibodies with exceptional therapeutic properties generated through their Reverse Translational Medicine™ (RTM™) technology platform.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2015-03-01, Month

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$10M
Last funding
Series A / $10M / 2019-03-04
Last equity funding
Series A / $10M
Investors
3
Lead investors
2
Founders
2
Articles
8

Founders and investors

Founders

Martin E. SchwabRoger M Nitsch

Lead investors

Neurimmune HoldingPureos Bioventures

Investors

Kinled HoldingNeurimmune HoldingPureos Bioventures